202 related articles for article (PubMed ID: 3283041)
1. A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora.
Edlund C; Nord CE
Infection; 1988; 16(1):8-12. PubMed ID: 3283041
[TBL] [Abstract][Full Text] [Related]
2. Effect of new quinolones on the human gastrointestinal microflora.
Nord CE
Rev Infect Dis; 1988; 10 Suppl 1():S193-6. PubMed ID: 3279492
[TBL] [Abstract][Full Text] [Related]
3. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
Renaudin H; Quentin C; de Barbeyrac B; Bebear C
Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin.
Van der Auwera P
Infection; 1986; 14(3):142-4. PubMed ID: 2942489
[TBL] [Abstract][Full Text] [Related]
5. In-vitro activity of newer quinolones against aerobic bacteria.
Auckenthaler R; Michéa-Hamzehpour M; Pechère JC
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
Arpi M; Gahrn-Hansen B; Søgaard P; Bentzon MW
Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910
[TBL] [Abstract][Full Text] [Related]
7. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
King A; Phillips I
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
[TBL] [Abstract][Full Text] [Related]
8. Manipulation of the oropharyngeal and intestinal microflora by norfloxacin: microbiological and clinical aspects.
Edlund C; Nord CE
Scand J Infect Dis Suppl; 1988; 56():14-21. PubMed ID: 3074461
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activities of ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile.
Edlund C; Nord CE
Scand J Infect Dis; 1986; 18(2):149-51. PubMed ID: 2939556
[TBL] [Abstract][Full Text] [Related]
10. Effect of quinolones on intestinal ecology.
Edlund C; Nord CE
Drugs; 1999; 58 Suppl 2():65-70. PubMed ID: 10553709
[TBL] [Abstract][Full Text] [Related]
11. Effect of quinolones on the human intestinal microflora.
Nord CE
Drugs; 1995; 49 Suppl 2():81-5. PubMed ID: 8549421
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of five new quinolones against 88 genital and neonatal Haemophilus isolates.
Quentin R; Koubaa N; Cattier B; Gavignet M; Goudeau A
Antimicrob Agents Chemother; 1988 Jan; 32(1):147-9. PubMed ID: 3258143
[TBL] [Abstract][Full Text] [Related]
13. [Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
Habiyaremye I; Verbist L; Vandepitte J
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):800-4. PubMed ID: 3116489
[TBL] [Abstract][Full Text] [Related]
14. Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
Davies S; Sparham PD; Spencer RC
J Antimicrob Chemother; 1987 May; 19(5):605-9. PubMed ID: 3112094
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.
Delmee M; Avesani V
Antimicrob Agents Chemother; 1986 Feb; 29(2):374-5. PubMed ID: 2940968
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of newer quinolones: influence on normal microflora.
Nord CE; Edlund C
J Chemother; 1989 Feb; 1(1):18-23. PubMed ID: 2656927
[TBL] [Abstract][Full Text] [Related]
17. The comparative pharmacokinetics of five quinolones.
Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():71-81. PubMed ID: 3468102
[TBL] [Abstract][Full Text] [Related]
18. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
Bassey CM; Baltch AL; Smith RP
J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test.
Barry AL; Jones RN
Eur J Clin Microbiol; 1987 Apr; 6(2):179-82. PubMed ID: 3474145
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro studies with 4-quinolone antimicrobials.
Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
